Nordic Bioproducts Group launches commercial-scale production of microcrystalline cellulose
In Finland, Nordic Bioproducts Group (NBG), a leader in biomaterial innovation and developer of proprietary AaltoCellTM Technology, announces the opening of its commercial-scale production facility for microcrystalline cellulose (MCC) and other cellulose derivatives in Lappeenranta, Finland. This first-of-its-kind facility represents a significant leap in manufacturing, enabling continuous and sustainable production at scale. Featuring the world’s […]